TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
Novo Nordisk Pharma Operations A/S
Closing information (x1000 NOK)
| Closing information | 2021/12 | 2020/12 | 2019/12 |
| Turnover |
132,282
|
111,942
|
107,005 |
| Earnings before taxes |
5,899
|
5,276
|
5,108 |
| Total assets |
95,037
|
77,282
|
73,831 |
| Current assets |
80,258
|
68,594
|
58,410 |
| Current liabilities |
56,991
|
52,017
|
50,499 |
| Equity capital |
27,545
|
24,570
|
18,972 |
| - share capital |
671
|
707
|
660 |
| Employees (average) |
0
|
0
|
0 |
Financial ratios
| Fiscal year | 2021/12 | 2020/12 | 2019/12 |
| Solvency |
29.0%
|
31.8%
|
25.7% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
4.5%
|
4.7%
|
4.8% |
| Return on assets (ROA) | |||
| Current ratio |
140.8%
|
131.9%
|
115.7% |
| Return on equity (ROE) |
21.4%
|
21.5%
|
26.9% |
| Change turnover |
26,063
|
-2,608
|
25,986 |
| Change turnover % |
25%
|
-2%
|
32% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2021/12 | 2020/12 | 2019/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.